You are viewing: France Periodontal Disease Treatment Market analysis

The France Periodontal Disease Treatment Market was valued at $41.55 Million in 2024 and projected to reach to $54.73 Million by 2029, representing a compound annual growth rate of 4.7%. France's periodontal disease treatment market is positioned for steady growth through 2029, supported by an aging population with higher prevalence of periodontal conditions and increased investment in dental healthcare infrastructure.

France Periodontal Disease Treatment Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

France Periodontal Disease Treatment Market Trends and Insights

  • This steady expansion reflects increasing awareness of oral health in France and rising demand for advanced periodontal therapies among both patients and dental practitioners.
  • France's well-established healthcare infrastructure and strong reimbursement policies support market growth, positioning the country as a significant contributor to European periodontal treatment innovation. The French market benefits from a growing aging population with higher prevalence of periodontal disease and improved access to specialized dental care.
  • Between 2024 and 2029, France is expected to see increased adoption of minimally invasive treatment techniques and digital diagnostic tools.
  • Healthcare investments and patient education initiatives across France are driving demand for both preventive and restorative periodontal solutions, creating opportunities for market participants to expand their presence in this mature European market..

Key Market Statistics

  • CAGR (2024-2029) 4.7% CAGR
  • Market Size, 2024 ~USD 41.55 Million
  • Forecast, 2029 ~USD 54.73 Million
  • Country France

France Periodontal Disease Treatment Market Overview

Market Valuation :

France's periodontal disease treatment market reached $41.55 million in 2024, with projections to expand to $54.73 million by 2029, demonstrating consistent market growth driven by healthcare investments and patient awareness.

Growth Trajectory :

The French market exhibits a 4.7% CAGR through 2029, slightly below the global average of 5.9%, reflecting a mature but stable healthcare market with steady demand for periodontal interventions.

Healthcare Infrastructure :

France's robust healthcare system and high dental care accessibility support market expansion, with strong reimbursement policies encouraging adoption of advanced periodontal treatment modalities among dental practitioners.

Patient Awareness Trends :

Increasing oral health consciousness among French patients, coupled with preventive care initiatives, is driving demand for professional periodontal treatments and contributing to market value growth.

France Periodontal Disease Treatment Market Dynamics

  • The French healthcare system's emphasis on preventive care and patient education continues to elevate awareness of periodontal disease risks, encouraging earlier intervention and professional treatment adoption. The market will benefit from technological advancements in minimally invasive periodontal procedures and growing integration of digital dentistry solutions.
  • With strong reimbursement mechanisms and a well-educated patient base, France represents a stable market for periodontal treatment providers seeking to expand their presence in Western Europe..

Market Ecosystem

logo-mobile
Market Size
$2.86B
MARKET SIZE, 2026
Projected Market Size
$3.86B
MARKET SIZE, 2031
CAGR
6.2%
CAGR (2026-2031)
Forecast Period
2026-2031
FORECAST PERIOD

OVERVIEW

periodontal-disease-treatment-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global periodontal disease treatment market, valued at USD 2.71 billion in 2025, stood at USD 2.86 billion in 2026 and is projected to advance at a resilient CAGR of 6.2% from 2026 to 2031, culminating in a forecasted valuation of USD 3.86 billion by the end of the period. Poor oral hygiene practices, change in lifestyle, smoking habits, and the geriatric population are some of the major reasons contributing to increasing cases of periodontal diseases, hence driving the market. Greater awareness of oral health and an intensifying relationship between oral health and systemic health have encouraged many patients to visit dental health services for prevention and treatment purposes. Minimally invasive surgical treatments, laser treatment, and advanced diagnostic treatment options have facilitated the effective management of periodontal diseases; treatment has become easier and painless, thus reducing the stress associated with treatment. In addition, the growth of private dental practices and dental departments within hospitals, rising affluence, and increased emphasis on regular dental health visits will continue to drive the demand for periodontal disease treatment.

KEY TAKEAWAYS

  • MARKET SNAPSHOT:
    Base Year Market Size (2025): USD 2.71 Billion
    Current Market Size (2026): USD 2.86 Billion
    Forecast Market Size (2031): USD 3.86 Billion
    CAGR (2026–2031): 6.2%
  • SEGMENT LEADERSHIP:
    Regional Leader: Europe accounted for a 36.2% share of the periodontal disease treatment market in 2025.
    Product Leader: Equipment accounted for the largest share of 50.6% in 2025.
    Disease Type Leader: Gingivitis accounted for the largest share of the periodontal disease treatment market in 2025.
    Treatment Type Leader: Non-surgical treatment accounted for the largest share of the periodontal disease treatment market in 2025.
    End User Leader: Hospitals held the largest share of approximately 54.0% in 2025.
  • MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
    Dentsply Sirona (US) and Henry Schein, Inc. (US) were recognized as star players due to their established strong product portfolios.
    Companies such as Overjet have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The global periodontal disease treatment market has been witnessing significant growth, mainly as a result of a higher level of awareness about oral health, the increased occurrence of periodontal diseases, and the availability of advanced dental care solutions. Some of the key factors behind the increased incidence of gum diseases are the rising elderly population, growing number of smokers and diabetics, and the adoption of different lifestyle habits, which in turn have led to a rising demand for periodontal treatments, both preventive and therapeutic. The market is also benefiting from innovations in treatment methods, such as minimally invasive surgical procedures, the use of lasers, and the creation of new biomaterials and regenerative products.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The market for periodontal disease treatment is undergoing a massive change because of the trends and disruptions that are impacting the needs of the dental care providers and patients. A move away from the traditional consumables and medication-based revenue streams to more advanced periodontal technology, minimally invasive surgery, and digital diagnostic capabilities indicates a higher demand for early intervention, precise treatment, and chronic disease management. Hospitals, dental practices, group practices, and Dental Service Organizations (DSOs) are realizing the need for greater clinical efficiency, better workflow, minimal pain and discomfort for patients, and alignment with the increasing dental care standards. These forces are driving the need for innovative technologies and maintenance-based treatment modalities, resulting in overall superior clinical outcomes, patient satisfaction, operational efficiencies, and growth in the periodontal disease treatment market.

periodontal-disease-treatment-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing prevalence of oral health disorders
  • Rising cases of edentulism
RESTRAINTS
Impact
Level
  • High cost of advanced treatments and inadequate reimbursements for dental procedures
OPPORTUNITIES
Impact
Level
  • Impact of DSOs on dental industry
  • Growing awareness about oral health
CHALLENGES
Impact
Level
  • Shortage of skilled dental practitioners

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing prevalence of oral health disorders

Growth in the incidence of oral health problems is the primary factor driving the periodontal disease treatment market. The risk of periodontal diseases has been significantly elevated due to the mixture of different factors such as bad oral habits, high consumption of sugar, smoking, stress, diabetes, and aging populations. Should these diseases go untreated, the patients will be in an ever-increasing need of preventive and therapeutic periodontal treatments. The increase in oral health problems has also resulted in higher awareness among patients and doctors, which in turn leads to early diagnosis and prompt treatment, and thus, the market of periodontal disease treatment keeps expanding.

Restraint: High cost of advanced treatments and inadequate reimbursements for dental procedures

High cost of advanced therapies, as well as poor reimbursement rates for dental procedures, are some of the key factors inhibiting the growth of the periodontal disease treatment industry. Advanced periodontal therapy, such as that involving lasers, regenerative procedures, or complex surgeries, may involve expensive infrastructure. In some regions, many dental procedures may not be covered or, in some cases, may be completely excluded from standard health insurance plans. As such, many patients may have to pay out of their pockets, which may act as a deterring factor in seeking timely or advanced periodontal treatment.

Opportunity: Impact of DSOs on dental industry

The increasing presence of Dental Service Organizations (DSOs) represents an important opportunity in the periodontal disease treatment market with respect to the reformation of dental care delivery. DSOs assist dental practices by providing organization and support in relation to purchasing, technology implementation, and administration, thereby ensuring that practices function in a more effective and efficient manner and are oriented towards better patient care. DSOs with increasing presence enable greater standardization of periodontal treatment approaches, advanced technological implementation in practices, and better access to specialized care for periodontitis in various locations. In addition to this, DSOs increase patient access due to improved recognition and simpler pricing structures, along with greater recognition by various insurance providers, thereby promoting larger volumes of treatment.

Challenge: Shortage of skilled dental practitioners

The challenge of a lack of skilled dental practitioners affects the development of the periodontal disease treatment market. Both conventional and advanced treatments require specialized skills that are not available on a similar level in all regions across the world. For instance, in some developing countries, it may be hard to access periodontists and skilled dental practitioners due to limited numbers of skilled professionals, resulting in a lack of quick and effective treatment for patients with periodontal disease. This hampers the development of the periodontal disease treatment market and slows its overall growth due to a shortage of skilled dental practitioners.

PERIODONTAL DISEASE TREATMENT MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
The company manufactures resorbable or non-resorbable barrier membranes, which can be used for guided tissue regeneration or guided bone regeneration. This is done by acting as a barrier between the soft tissue and the bone, allowing cells to repopulate the area selectively. This process helps to regenerate the periodontal ligaments, cementum, and alveolar bone. Dentsply Sirona membranes improve clinical results by facilitating predictable tissue regeneration, as well as providing better wound stability. Biocompatibility, as well as the ability to be resorbed, reduces the reliance on further surgical interventions, enhancing the efficiency of the healing process while allowing the achievement of periodontal stability.
The company has specialized in the delivery of regenerative periodontal products, biomaterials, and adjunctive regenerative devices that are used in treating periodontal defects caused by advanced gum diseases. These are usually applied in periodontic flap surgeries to help in the regeneration of bone and tissue in the affected areas and to support the tooth structure. The regenerative solutions developed by Envista optimize predictability and promote rapid healing of tissues by improving biological integration in the defect area. The products help healthcare professionals efficiently tackle complex cases related to periodontal diseases and optimize tooth retention, thus ensuring enhanced patient satisfaction and efficiency in practices.
Institut Straumann Holdings AG has advanced tissue-regenerative materials such as biologics and biomaterials for use in periodontal regeneration. These materials are useful in regenerating periodontal structures by promoting the growth of natural tissues in the case of severe periodontitis and/or peri-implant defects. Straumann's tissue regenerative materials enhance regenerative outcomes by encouraging bodily healing and facilitating soft and hard tissue integration. The clinically proven efficacy of Straumann's materials shortens healing time, improves long-term stability of periodontal conditions, and makes minimally invasive surgeries possible, which benefits dentists and patients in many ways.
Henry Schein, Inc. offers various types of bone grafting materials that are employed in the treatment of periodontal disease for the regeneration of alveolar bone damaged because of chronic periodontitis. These products find their applications in the treatment of periodontal and implant-related disorders. Henry Schein's bone grafting products support reliable bone regeneration and strengthen the jaw. This extensive product line allows dental professionals to select the appropriate products to address bone defects, thereby improving ease of treatment, outcomes, and overall periodontal health.
Nakanishi Inc. offers advanced oral care tools, such as high-speed handpieces and professional oral care tools, which are employed for periodontal therapy procedures like scaling, root planing, as well as plaque removal. The company's oral hygiene products increase the efficiency of treatments through their ability to remove plaque and calculus without significant discomfort to the patient. These products have been designed for efficiency and functionality, which will increase clinical efficiency and the management of periodontal diseases through improved hygiene practices.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The periodontal disease treatment market includes several manufacturers, distributors, end users, and regulatory bodies, which operate together to develop, distribute, and allow for the adoption of periodontal treatment-related products. Major manufacturers such as Nakanishi, Yoshida, Ultradent Products, Geistlich Biomaterials, and Henry Schein Inc. offer high-end dental equipment, biomaterials, and surgical instruments. The distribution chain includes distributors such as Henry Schein Inc., BIOLASE Inc., MORITA, Regenity Ltd., and AMD LASERS. End users of these products include major health organizations and dental practices such as AdventHealth, Mount Sinai, Mayo Clinic, Cleveland Clinic, Johns Hopkins Medicine, and NHS Barts Health Hospitals. Regulatory authorities in this market, such as the US FDA, the UK EMA, and India's CDSCO, ensure that the quality of the product, its safety, effectiveness, and adherence to international standards are ensured; therefore, this market is also well-structured.

periodontal-disease-treatment-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

periodontal-disease-treatment-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Periodontal Disease Treatment Market, By Product

Equipment currently holds the largest market share, as it is a requirement in the diagnosis, prevention, as well as treatment of periodontal diseases. Equipment like ultrasonic scalers, lasers, surgery items, imaging solutions, as well as treatment chairs, is commonly required in non-surgical as well as surgical periodontal treatment, which ensures steady sales of such items. Technological advancements related to solutions such as lasers, minimally invasive surgery, and computerized diagnostics have also aided in cementing this particular market share. Further, advancements related to steady improvements of such solutions to reduce treatment time, along with increasing usage of periodontal solutions, have aided in increasing this particular.

Periodontal Disease Treatment Market, By Disease Type

Gingivitis holds the largest share mainly because of its high prevalence, being the most widely reported disorder across all age groups. Being the first and most widespread stage of periodontal disease, gingivitis is generally noticed upon routine dental examinations, and this leads to a great number of people going for treatment. Since the disease can be reversed if treatment is given on time, there is a strong demand for preventive and non-surgical dental care procedures such as professional dental cleaning, scaling, and oral hygiene maintenance. More and more people are becoming aware of oral health and preventive dental care, which has made gingivitis the dominant disease type in the periodontal disease treatment market.

Periodontal Disease Treatment Market, By Treatment Type

Non-surgical treatment represents the highest segment of the market, by treatment type. It is widely used as a primary intervention for the management of periodontal conditions, especially gingivitis and early-stage periodontitis. On the other hand, minimally invasive and more affordable procedures such as scaling and root planing, professional dental cleaning, and antimicrobial therapy represent a preferable option for patients and dental professionals. Such treatments are usually performed on the occasion of a routine dental check and do not require complicated surgical infrastructure, which justifies their broad dispersal across dental clinics. The rising emphasis on prevention, early diagnosis, and continuous maintenance therapy further supports the leading position of non-surgical treatment within the periodontal disease treatment market.

Periodontal Disease Treatment Market, By End User

Hospitals hold a considerable share of the periodontal disease treatment end-user market. They can offer comprehensive periodontal and dental care in the same environment. They have the latest diagnostic imaging technology, top-notch surgical facilities, and expert dental professionals, enabling them to not only provide general treatments but also perform complex periodontal surgeries. Moreover, hospitals have a wide patient base, including advanced periodontal cases or patients with other health conditions who need coordinated, multidisciplinary care. Besides, the use of advanced treatment methods, compliance with strict infection control protocols, and higher patient trust in hospital-based services are some of the factors that have helped hospitals to maintain the dominant position in the periodontal disease treatment market.

REGION

Middle East & Africa to be fastest-growing region in the periodontal disease treatment market during forecast period

The Middle East and Africa (MEA) region is being recognized as the fastest-growing market for periodontal disease treatment as a result of demographic, epidemiological, and healthcare system factors. Due to low levels of oral hygiene awareness, high tobacco use, rising diabetes rates, and changing eating habits, especially in urban areas, the region is experiencing an increase in the prevalence of periodontal diseases. Rapid population growth and a large number of untreated patients also lead to the increased demand for periodontal therapies. Besides that, local governments in the Gulf Cooperation Council (GCC) countries and some African nations are raising their healthcare budgets and modernizing their dental infrastructures, which is facilitating access to advanced periodontal treatments such as scaling and root planing, laser therapy, and regenerative procedures. The growth of dental tourism in the UAE and Turkey, as well as the development of private dental clinics and specialty centers, is contributing to the market expansion.

periodontal-disease-treatment-market Region

PERIODONTAL DISEASE TREATMENT MARKET: COMPANY EVALUATION MATRIX

In the periodontal disease treatment market matrix, Dentsply Sirona (US) (Star) and Henry Schein, Inc. (US) (Star) lead with their unmatched global presence, strong brand recognition, and comprehensive portfolios of periodontal disease treatment. Yoshida Dental MFG. Co., Ltd. (Japan) (Emerging Leader) is rapidly gaining traction with its versatile medical gas and equipment products for therapeutic and diagnostic applications.

periodontal-disease-treatment-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 2.71 Billion
Market Forecast in 2031 (Value) USD 3.86 Billion
Growth Rate CAGR of 6.2% from 2026-2031
Years Considered 2025-2031
Base Year 2025
Forecast Period 2026-2031
Units Considered Value (USD Million/Billion), Volume (Thousands Units)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By Product:
    • Equipment
    • Consumables
    • Medications
  • By Disease Type:
    • Gingivitis
    • Chronic Periodontitis
    • Others
  • Gingivitis:
    • Acute
    • Recurrent
    • Chronic
  • By Treatment Type:
    • Non-surgical Treatment
    • Flab Surgery/Pocket Reduction Therapy
    • Soft Tissue Graft
    • Bone Grafting
    • Guided Tissue Regeneration
    • Other Treatments
  • Non-surgical Treatment:
    • Scaling
    • Root Planning Medication Therapy (Topical Therapy
    • Systemic Therapy)
  • By End User:
    • Hospitals
    • Private & DSO Clinics
    • Academic & Research Institutions
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa, GCC Countries
Related Segment & Geographic Reports US Periodontal Disease Treatment Market
APAC Periodontal Disease Treatment Market

WHAT IS IN IT FOR YOU: PERIODONTAL DISEASE TREATMENT MARKET REPORT CONTENT GUIDE

periodontal-disease-treatment-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Volume Analysis Market assessment by volume (units) for dental equipment used in digital dentures ecosystem
  • Insights on product demand by volume
  • YOY growth (%) and demand for key categories
Product Analysis Further breakdown of other applications in the market Insights on other applications involved in the market
Company Information
  • Key players: Dentsply Sirona (US), Henry Schein, Inc. (US), Envista Holdings Corporation (US), Nakanishi Inc. (Japan), Yoshida Dental MFG. Co., Ltd. (Japan), Institut Straumann Holdings AG (Switzerland)
  • Top 3-5 players market share analysis at the country level
Insights on market share analysis by country
Geographic Analysis
  • Detailed analysis on Rest of APAC was provided to one of the top players
  • Client focused on ASEAN market country-level analysis for the device market
Country-level demand mapping for new product launches and localization strategy planning

RECENT DEVELOPMENTS

  • October 2025 : BIOLASE showcased a YSGG laser-assisted periodontitis treatment protocol at the AAP 2025 Corporate Forum, highlighting a minimally invasive approach that improves bacterial reduction, preserves healthy tissue, and enhances healing outcomes in periodontal pocket treatment.
  • July 2025 : Envista expanded its manufacturing footprint with a new facility in China to strengthen regional supply, improve operational efficiency, and support growing demand for dental and periodontal care products in the Asia Pacific market.

 

Related Ecosystem

Dental Devices

Top Technologies
  • Dental Implants
  • Dental Bone Grafts
  • Dental Crowns
  • Dental Prosthetics
  • Zirconium Implants
Top Companies
  • DENTSPLY SIRONA Inc.
  • Henry Schein, Inc.
  • KAVO KERR GROUP
  • PLANMECA GROUP
  • Patterson Companies, Inc.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • France's periodontal disease treatment market is valued at $41.55 million in 2024 and will reach $54.73 million by 2029, growing at 4.7% CAGR.
      • France's aging population and strong healthcare reimbursement system are primary drivers of market expansion through 2029.
      • Minimally invasive techniques and digital diagnostics are gaining traction in France's periodontal treatment landscape.
      • France's mature dental infrastructure positions it as a stable, innovation-focused market within the European region.

      Periodontal Disease Treatment Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment AGGRESSIVE PERIODONTITIS (Disease)
      Forecast Period 2024–2029
      Growth Rate CAGR of 5.9% from 2024 to 2029
      Largest Segment NON-SURGICAL TREATMENT (Treatment)
      Market Size Base Year (Billions) ~USD 2.57 (2024)
      Revenue Forecast (Billions) ~USD 3.43 (2029)
      Segments Covered Product, Disease, Type, Treatment

      France Periodontal Disease Treatment Market Report Segmentation

      4 segment dimensions are covered across the global market.

      By Product

      • Consumables
      • Equipment
      • Medication

      By Disease

      • Aggressive Periodontitis
      • Chronic Periodontitis
      • Gingivitis
      • Other Diseases

      By Type

      • Acute Gingivitis
      • Chronic Gingivitis
      • Medication Therapy
      • Recurrent Gingivitis
      • Root Planing
      • Scaling

      By Treatment

      • Bone Grafting
      • Flap Surgery/Pocket Reduction Therapy
      • Guided Tissue Regeneration
      • Non-Surgical Treatment
      • Other Treatments
      • Soft Tissue Graft

      FRANCE: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030

      Segment202220232024202520262027202820292030CAGR (%)
      ACADEMIC & RESEARCH INSTITUTES9.79.910.110.410.610.911.111.511.82.6
      DSOS & INDEPENDENT CLINICS26.327.12828.929.830.83233.234.53.5
      HOSPITALS40.74345.347.850.553.456.66063.85.9
      TOTAL76.78083.487.190.995.199.7104.71104.7

      Target Audience

      • Dental Device Manufacturers : Manufacturers of periodontal instruments, implants, and treatment devices need France-specific market data to assess market size, growth potential, and competitive positioning for product launches and distribution partnerships.
      • Pharmaceutical Companies : Pharmaceutical firms developing periodontal medications and biologics require detailed French market insights to evaluate commercial viability, reimbursement landscapes, and patient adoption rates for new therapies.
      • Dental Practice Groups & Clinics : Dental practitioners and clinic operators in France need market intelligence to justify investment in advanced periodontal services, understand patient demand trends, and optimize service offerings for profitability.
      • Healthcare Investors & PE Firms : Investment firms evaluating dental healthcare opportunities in France require validated market data, growth forecasts, and competitive analysis to make informed investment decisions and identify acquisition targets.
      • Healthcare Consultants & Advisors : Consulting firms advising healthcare clients on market expansion, service development, and strategic planning need France-specific periodontal market data to provide credible recommendations and competitive benchmarking.

      Key Companies in the France Periodontal Disease Treatment Market

      CompanyHQOwnershipStrongest segments
      DENTSPLY SIRONAUnited StatesPublic CompanyConnected Technology Solutions,Essential Dental Solutions,Orthodontic and Implant Solutions,
      ENVISTA HOLDINGS CORPORATIONUnited StatesPublic CompanySpecialty Products & Technologies – Implants & Biomaterials,Specialty Products & Technologies – Orthodontics & Clear Aligners,Equipment & Consumables – Imaging, Software & Visualization,
      HENRY SCHEIN, INC.United StatesPublic CompanyGlobal Distribution and Value-Added Services,Global Specialty Products,Global Technology,
      BIOLASE, INC.United StatesPublic CompanyWaterlase all-tissue systems,Diode soft-tissue systems,Consumables, fibers, and handpieces,
      NAKANISHI INC.JapanPublic CompanyDental handpieces (air turbines, contra-angles, micromotors),Surgical and mobile dentistry systems,Dental lab, hygiene, and maintenance products,
      A-DEC INC.SwitzerlandPublic CompanyFlexible placement (temporary staffing and contracting),Permanent placement and career transition,Outsourcing and engineering consulting,

      DENTSPLY SIRONA

      DENTSPLY SIRONA is a United States-based public company founded in 1877 with 14,000 employees. The company operates in the dental industry.

      ENVISTA HOLDINGS CORPORATION

      ENVISTA HOLDINGS CORPORATION is a United States-based public company founded in 2018 with 12,000 employees. The company operates in the dental industry.

      HENRY SCHEIN, INC.

      HENRY SCHEIN, INC. is a United States-based public company founded in 1932 with 25,000 employees. The company operates in the dental industry.

      BIOLASE, INC.

      BIOLASE, INC. is a United States-based public company founded in 1984 with 157 employees. The company operates in the dental industry.

      NAKANISHI INC.

      NAKANISHI INC. is a Japan-based public company founded in 1930 with 2,204 employees. The company operates in the dental industry.

      A-DEC INC.

      A-DEC INC. is a Switzerland-based public company founded in 1957 with 33,569 employees. The company operates in the dental industry.

      Reasons to Buy this Report

      • Precise Market Sizing : Access validated market valuation data specific to France ($41.55M in 2024), enabling accurate budget allocation and revenue forecasting for periodontal treatment investments in the French healthcare sector.
      • Competitive Intelligence : Understand France's unique market dynamics, healthcare reimbursement structures, and patient demographics to identify competitive advantages and develop targeted market entry or expansion strategies.
      • Growth Opportunity Assessment : Leverage 4.7% CAGR projections through 2029 to evaluate long-term viability of periodontal treatment ventures in France and benchmark performance against global market trends at 5.9% growth.
      • Stakeholder Decision Support : Equip investors, dental practitioners, and healthcare administrators with France-specific market data to support funding decisions, partnership evaluations, and clinical service expansion planning.
      • Regulatory & Market Context : Gain insights into France's healthcare infrastructure, patient awareness levels, and treatment adoption patterns to navigate regulatory requirements and optimize product-market fit for periodontal solutions.

      Frequently asked questions

      What is the current size of France's periodontal disease treatment market?

      France's periodontal disease treatment market was valued at $41.55 million in 2024.

      What is the projected market size for France by 2029?

      France's periodontal disease treatment market is projected to reach $54.73 million by 2029.

      What is the growth rate of France's periodontal disease treatment market?

      France's periodontal disease treatment market is expected to grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2029.

      What factors are driving growth in France's periodontal treatment market?

      Key drivers include France's aging population, strong healthcare reimbursement policies, increased oral health awareness, and adoption of advanced treatment technologies.

      Which treatment trends are emerging in France's periodontal market?

      Minimally invasive treatment techniques, digital diagnostic tools, and preventive care solutions are gaining prominence in France's periodontal disease treatment landscape.

      RESEARCH METHODOLOGY

      Get the Full Periodontal Disease Treatment Market Report

      Full forecast, segment splits, and company analysis for all Periodontal Disease Treatment Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status